Can Vaping CBD Oil Help Anxiety? What the Research Actually Shows

CBD is often sold on the back of anxiety headlines. The research behind those headlines is real but small, and UK rules stop any CBD food or vape product from claiming to treat anxiety. This article sets out what has been studied, what has not, and how to read products responsibly.

This article is general information, not medical advice. Cannabinoid products sold by THC Vape Stores are not medicines and are not intended to diagnose, treat, cure or prevent any condition. If you have a health condition, take medication, or are pregnant or breastfeeding, speak to a healthcare professional before using any cannabinoid product. Adults 18+ only.

What is CBD, and what is it not?

Cannabidiol (CBD) is a non-intoxicating cannabinoid from hemp. In the UK it is sold as a food supplement, a cosmetic or a vaping product – not as a medicine. The only CBD medicine licensed in the UK, Epidyolex, is prescribed for specific severe childhood epilepsies. Products sold as supplements or vapes cannot legally claim to treat, prevent or cure a condition, including anxiety. For the basics see THC vs CBD: what is the difference.

What anxiety is

Anxiety disorders – generalised anxiety, social anxiety, panic disorder, PTSD and OCD – are the most common mental health conditions. The NHS-recommended first-line approaches are talking therapies (especially CBT), self-help programmes and, where appropriate, prescribed medication. If anxiety is affecting your daily life, a GP or NHS Talking Therapies referral is the right first step, not a supplement.

The studies people quote

• Crippa et al., 2011 – brain imaging in 10 people with social anxiety after a single 400 mg oral CBD dose showed changes in activity in regions linked to anxiety. Ten participants, one dose.
• Bergamaschi et al., 2011 (Neuropsychopharmacology) – 24 treatment-naïve people with social anxiety took 600 mg of oral CBD or placebo before a simulated public-speaking test; the CBD group reported less anxiety and discomfort. One dose, one situation, a dose far above anything in a consumer product.
• Blessing et al., 2015 – a review of preclinical and early human work concluded CBD “has considerable potential” for anxiety disorders but that chronic-dosing trials in people were lacking.
• Shannon et al., 2019 – a retrospective chart review of 72 psychiatric patients given 25–75 mg CBD a day; 79% had lower anxiety scores in the first month. No placebo group, no blinding.

Common threads: small numbers, single or short-term dosing, doses of 300–600 mg that are 30–60 times the FSA’s daily guidance for consumers, and few placebo-controlled trials. That is why regulators do not permit anxiety claims on CBD products.

What about vaping specifically?

Inhaled CBD reaches the bloodstream faster than swallowed CBD, but no controlled trial has tested vaped CBD for anxiety. Vaping also carries its own considerations – see THC vape vs CBD vape and what to look for in any vape product.

Safety and dosing in the UK

The Food Standards Agency advises healthy adults not to take more than 10 mg of CBD a day from food supplements, and says CBD is not recommended for under-18s, people taking medication, or anyone pregnant or breastfeeding. The World Health Organization’s 2018 review found CBD generally well tolerated, with possible interactions with other medicines (CBD affects liver enzymes that process many drugs) – another reason to talk to a pharmacist or GP if you take medication. Our CBD oil strength guide explains how bottle strength converts to milligrams per drop.

How to read a CBD product responsibly

• Look for the CBD content per bottle and per serving, the spectrum (isolate, broad or full) and a batch Certificate of Analysis – what to check before buying CBD.
• Treat “for anxiety”, “calming formula” or similar wording on packaging as marketing; UK advertising rules do not allow medicinal claims for CBD foods and vapes.
• Do not stop or change prescribed medication in favour of CBD without medical advice.

Sources: Crippa et al. (2011) Journal of Psychopharmacology; Bergamaschi et al. (2011) Neuropsychopharmacology; Blessing et al. (2015) Neurotherapeutics; Shannon et al. (2019) The Permanente Journal; WHO Expert Committee on Drug Dependence, Cannabidiol Critical Review (2018); Food Standards Agency consumer advice on CBD; NHS guidance on anxiety.